/images/ppid_59c68470-image-176292503019572759.webp)
What is the story about?
Shares of IOL Chemicals and Pharmaceuticals Ltd. surged as much as 13% on Wednesday, November 12, after the company reported a robust set of earnings for the September quarter, with strong growth across all key metrics.
The company's net profit rose 56.3% year-on-year to ₹30 crore, compared with ₹19.2 crore in the same quarter last year.
Revenue increased 8% to ₹567.5 crore from ₹525.8 crore, while EBITDA climbed 37% to ₹57 crore from ₹41.6 crore a year ago.
Operating margins expanded to 10% from 7.9% in the corresponding quarter last year.
The stock was trading with sharp gains on the back of the strong performance.
The company's net profit rose 56.3% year-on-year to ₹30 crore, compared with ₹19.2 crore in the same quarter last year.
Revenue increased 8% to ₹567.5 crore from ₹525.8 crore, while EBITDA climbed 37% to ₹57 crore from ₹41.6 crore a year ago.
Operating margins expanded to 10% from 7.9% in the corresponding quarter last year.
The stock was trading with sharp gains on the back of the strong performance.
/images/ppid_59c68470-image-177087752852386037.webp)
/images/ppid_59c68470-image-177087759367465250.webp)
/images/ppid_59c68470-image-177087755961297300.webp)
/images/ppid_59c68470-image-177087756975063071.webp)
/images/ppid_59c68470-image-177087752988933095.webp)
